GNS Healthcare predicts what works in healthcare and for whom. Our models and products, derived from massive quantities of patient data, are being applied across the healthcare industry: from pharmaceutical and biotechnology companies, health plans, and hospitals to integrated delivery systems, pharmacy benefits managers, and accountable care organizations. REFS is GNS Healthcare\'s scalable, supercomputer-enabled framework for discovering new knowledge from data. REFS automates the discovery of causal models from observational and experimental data and uses high-throughput simulations to generate new knowledge.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/30/14 | $10,000,000 | Series B |
Cambia Health Solutions Heritage Provider Network | undisclosed |
| 08/23/17 | $6,000,000 |
Alexandria Real Estate Equities Amgen Business Development | undisclosed | |
| 07/09/19 | $23,000,000 | Series D |
Alexandria Venture Investments Amgen Business Development Celgene Corporation Echo Health Ventures Gary Loveman | undisclosed |
